This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Colhoun HM, Dong W, Poulter NR Blood pressure screening, management and control in England: results from the health survey for England 1994 J Hypertens 1998 16 747–752
Chamontin B et alPrevalence, treatment, and control of hypertension in the French population: data from a survey on high blood pressure in general practice, 1994 Am J Hypertens 1998 11 759–762
Anonymous 1999 World Health Organization–International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Sub-Committee J Hypertens 1999 17 151–183
Anonymous The Sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Arch Int Med 1997 157 2413–2446
Wilson TW, Lacourcière Y, Barnes CC The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group CMAJ 1998 159 469–476
Moser M Myths, Misconceptions and Heroics. The Story of the Treatment of Hypertension from the 1930’s Le Jacq Communication 1997
Freis ED, Wanko A, Wilson IM, Parrish AE Treatment of essential hypertension with chlorothiazide (diuril). Its use alone and in combination with other antihypertensive agents JAMA 1958 166 137–140
Anonymous Effects of treatment on morbidity in hypertension. II. Results inpatients with diastolic blood pressure averaging 90 through 114 mm Hg JAMA 1970 213 1143–1152
Anonymous Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study JAMA 1977 237 255–261
Anonymous Five-year findings of the Hypertension Detection and Follow-up Program I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group JAMA 1979 242 2562–2571
Wikstrand J et alPrimary prevention with metoprolol inpatients with hypertension. Mortality results from the MAPHY study JAMA 1988 259 1976–1982
Wilhelmsen L et alBeta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial J Hypertens 1987 5 561–572
Anonymous Cardiovascular risk and risk factors in a randomized trial of treatment based on the betablocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group J Hypertens 1985 3 379–392
Anonymous MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party Br Med J 1985 291 97–104
Neaton JD et alTreatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group JAMA 1993 270 713–724
Materson BJ et alSingle-drug therapy for hypertension in men. A comparison of six antihypertensive drugs with placebo. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents N Engl J Med 1993 328 914–921
Materson BJ et alResponse to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department ofVeterans Affairs Cooperative Study Group on Anti-hypertensive Agents Arch Intern Med 1995 155 1757–1762
Hansson L et alRandomised trial of old and new antihypertensive drugs in elderlypatients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study Lancet 1999 354 1751–56
Weinberger MH Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension Br J Clin Pharmacol 1982 14 (Suppl 2) 127S–131S
Materson BJ, Reda DJ, Cushman WC, Henderson WG Results of combination anti-hypertensive therapy after failure of each of the components. Department ofVeterans Affairs Cooperative Study Group on Anti-hypertensive Agents J Hum Hypertens 1995 9 791–796
Hansson L The BBB Study: the effect of intensified antihypertensive treatment on the level of blood pressure, side-effects, morbidity and mortality in ‘well treated’ hypertensivepatients. Behandla Blodtryck Battre Blood Press 1994 3 248–254
Hansson L et alEffects of intensive blood-pressure lowering and low-dose aspirin inpatients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Hot Study Group Lancet 1998 351 1755–1762
Herpin D et alHypertension Optimal Treatment Study: efficacy and tolerability on the 36th month Arch Mal Cr 1998 91 1043–1048
Anonymous Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group BMJ 1998 317 703–713
Boumendil EF, Mugnier C Follow-up study of the use of antihypertensive drug treatment and of the population treated Am J Hypertens 1998 11 929–934
Epstein M, Bakris G Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy Arch Intern Med 1996 156 1969–1978
Frishman WH et alA multifactorial trial design to assess combination therapy in hypertension: treatment with bisoprolol and hydrochlorothiazide Arch Intern Med 1994 154 1461–1468
Chalmers J The use of free and fixed drug combinations to improve hypertension control in our populations Eur Heart J 1999 20 1060–1061
Bobrie G Les plurithérapies fixes microdosées en première intention dans le traitement de l’hypertension artérielle: rationnel et méthodologie de développement Lett Pharmacol 1998 12 133–138
Chalmers J Efficacy and acceptability of the fixed low-dose perindopril-indapamide combination as first-line therapy in hypertension Eur Heart J 1999 1 (Suppl L) L20–L25
Mallion JM, Chastang C, Unger P Efficacy and safety of a fixed low-dose perindopril/indapamide combination in essential hypertension. A randomised, controlled study Clin Exp Hypertens 2000 22 23–32
Castaigne A et alEfficacy and safety of an oral fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination: a randomised, double-blind, placebo-controlled study in elderlypatients with mild to moderate hypertension Clin Exp Hypertens 1999 21 1097–1110
Chalmers J, Castaigne A, Morgan T, Chastang C Long-term efficacy of a new, fixed, very low-dose angiotensin converting enzyme inhibitor/diuretic combination as first-line therapy in elderly hypertensivepatients J Hypertens 2000 18 327–337
SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 1991 265 3255–3264
Prisant LM et alLow-dose drug combination therapy: an alternative first-line approach to hypertension treatment Am Heart J 1995 130 359–366
Frishman WH Results of hypertension treatment with low-dose combinations of a beta-adrenergic blocker and a diuretic Am J Hypertens 1997 10 17S–23S
Benetos A, Gressin V, and the Working Group of the French Study ‘ULD in Systolic Hypertension’ Effects of ultra low-dose combination of bisoprolol/hydrochlorothiazide in systolic hypertension in the elderly Am J Hypertens 1998 11 109A
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Piot, O., Gallois, H., Baguet, JP. et al. First-line treatment of hypertension: from monotherapy to fixed low-dose combination therapy. J Hum Hypertens 15, 443–446 (2001). https://doi.org/10.1038/sj.jhh.1001204
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001204
Keywords
This article is cited by
-
Bridging Strategies for Drug Combinations in Pediatric Indications
Clinical Pharmacology & Therapeutics (2012)